BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1469141)

  • 1. Long-term management of basal cell nevus syndrome with topical tretinoin and 5-fluorouracil.
    Strange PR; Lang PG
    J Am Acad Dermatol; 1992 Nov; 27(5 Pt 2):842-5. PubMed ID: 1469141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of linear verrucous epidermal nevus with topical 5-fluorouracil and tretinoin.
    Nelson BR; Kolansky G; Gillard M; Ratner D; Johnson TM
    J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):287-8. PubMed ID: 8288798
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical tretinoin and 5-fluorouracil in the treatment of linear verrucous epidermal nevus.
    Kim JJ; Chang MW; Shwayder T
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):129-32. PubMed ID: 10863239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total body topical 5-fluorouracil for extensive non-melanoma skin cancer.
    van Ruth S; Jansman FG; Sanders CJ
    Pharm World Sci; 2006 Jun; 28(3):159-62. PubMed ID: 17004017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal cell nevus syndrome. Unresponsiveness of early cutaneous lesions to topical 5-fluorouracil or dinitrochlorobenzene.
    Hazen PG; Taub SJ
    Dermatologica; 1984; 168(6):287-9. PubMed ID: 6745474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approach to Gorlin syndrome: a patient treated with oral capecitabine.
    Beach DF; Somer R
    J Clin Oncol; 2011 May; 29(14):e397-401. PubMed ID: 21357787
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term retinoid therapy is needed for maintenance of cancer chemopreventive effect.
    Peck GL
    Dermatologica; 1987; 175 Suppl 1():138-44. PubMed ID: 3480250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical tretinoin in actinic keratosis and basal cell carcinoma.
    Peck GL
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):829-35. PubMed ID: 3534022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal cell nevus syndrome and adenocarcinoma of the colon. Response to systemic fluorouracil.
    Stone SP
    Int J Dermatol; 1979 Jun; 18(5):398-401. PubMed ID: 468461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical methyl aminolevulinate photodynamic therapy for management of basal cell carcinomas in patients with basal cell nevus syndrome improves patient's satisfaction and reduces the need for surgical procedures.
    Pauwels C; Mazereeuw-Hautier J; Basset-Seguin N; Livideanu C; Viraben R; Paul C; Meyer N
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):861-4. PubMed ID: 21668511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive treatment of basal cell carcinoma in nevoid basal cell carcinoma syndrome with 5-fluorouracil and salicylic acid.
    Yu Y; Zhang G; Fu S
    Dermatol Ther; 2022 Dec; 35(12):e15972. PubMed ID: 36346027
    [No Abstract]   [Full Text] [Related]  

  • 12. Sunscreen may prevent the development of basal cell carcinoma in individuals with basal cell carcinoma nevus syndrome: A retrospective survey study.
    Waldman RA; Grant-Kels JM
    J Am Acad Dermatol; 2019 Oct; 81(4):1028-1030. PubMed ID: 30928468
    [No Abstract]   [Full Text] [Related]  

  • 13. Hundreds of basal cell carcinomas in a Gorlin-Goltz syndrome patient cured with imiquimod 5% cream.
    Ferreres JR; Macaya A; JucglĂ  A; Muniesa C; Prats C; PeyrĂ­ J
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):877-8. PubMed ID: 16898919
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vitamin A acid for the topical management of epithelial neoplasms. Combination with 5-fluorouracil].
    Kurka M; Orfanos CE; Pullmann H
    Hautarzt; 1978 Jun; 29(6):313-8. PubMed ID: 659114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report.
    Micali G; De Pasquale R; Caltabiano R; Impallomeni R; Lacarrubba F
    J Dermatolog Treat; 2002 Sep; 13(3):123-7. PubMed ID: 12227875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of topical tretinoin in melanoma and dysplastic nevi.
    Meyskens FL; Edwards L; Levine NS
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):822-5. PubMed ID: 3534020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy using SnET2 for basal cell nevus syndrome: a case report.
    Rifkin R; Reed B; Hetzel F; Chen K
    Clin Ther; 1997; 19(4):639-41. PubMed ID: 9377609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tretinoin. A review of its pharmacological properties and clinical efficacy in the topical treatment of photodamaged skin.
    Noble S; Wagstaff AJ
    Drugs Aging; 1995 Jun; 6(6):479-96. PubMed ID: 7663068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on basal cell carcinoma rebound after cessation of vismodegib in an individual with basal cell nevus syndrome.
    Ally MS; Wysong A; Tang JY; Aasi S
    Dermatol Surg; 2013 Sep; 39(9):1413-4. PubMed ID: 23682843
    [No Abstract]   [Full Text] [Related]  

  • 20. A pediatric approach to management of skin growths in basal cell nevus syndrome.
    Fisher J; Moustafa D; Su KA; Bartenstein DW; Lilly E; Kroshinsky D; Hawryluk EB
    Pediatr Dermatol; 2020 May; 37(3):527-530. PubMed ID: 32065689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.